Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Stephen M. DeMoss who wrote (3453)	11/28/1999 11:47:00 PM
From: BARRY ALLEN	Respond to of 4140

Leza Sleza, Sturza Turdza, Avalon Crapalon, Pacific Atlantic, Goldfinger Silverfoot, Pink Stink, Pluvia Stupidia, Short Schmort. Relax everyone, SNRS is heading higher! The procedure works as my patients (in the FDA study) who are now more than 2 years out can testify! SNRS will prevail at the Jan. ODP, especially after the "reduction of Hyperopia" label! The shorts tell us that SNRS has no chance in hell for a number of reasons. One being TAX SELLING. Ok, let's see who will be tax selling come end of December. Will it be the SNRS long who bought in pre July ODP form $10-20?? Good chance he/she will not have much of a loss as SNRS ramps up prior to the Jan ODP. Well, looks like it will the shorts who recently sold at $7-8 betting that SNRS would get the March Panel instead of Jan, and the shorts that sold at $4-5 prior to the AAO/Kelman announcement, and the PIG shorts that STILL haven't covered their positions from the Post July ODP drop. So, how do shorts take their tax loss in December......they have to BUY...BUY...BUY to close their position to get their loss! ALL 8.1 MILLION OF THEM!!!!! Now what do you think that will do to the price of SNRS going into the Jan ODP??? Another thought.....anyone with Worden TC2000 can check this out. The day after the July debacle, there was heavy BOP selling for 3 days and the MoneyStream hit rock bottom. Recently BOP buying has come into SNRS but the MoneyStream has just begun to inch upward. The big and smart money on Wall Street entered SNRS with a vengence 2-3 weeks prior to the July ODP and bailed immediately afterward.(Wall Street doesn't like dead money--it realizes mistakes and puts it to work elsewhere) We now can expect that money to come back in over the next few weeks because Wall Street knows a winner. Watch SNRS start to ramp up in mid December and be fueled by the TAX BUYING of the remaining foolish shorts! SNRS has an excellent chance of blowing past it's old high of $20 3/8 well before the Jan ODP!

To: Stephen M. DeMoss who wrote (3453)	11/28/1999 11:51:00 PM
From: BARRY ALLEN	Read Replies (1) \| Respond to of 4140

Laser Eye Treatment Gains Popularity By DR. ROCK POSITANO Special to The News here are an estimated 120 million people in the U.S. who are nearsighted, farsighted or astigmatic. So common are these problems that, during the past five years, new and effective surgical techniques have emerged to address them. In the past people opted for corrective lenses and contact lenses — nowadays there is a tendency to consider permanent eyesight correction using laser technology. "Laser vision correction involves reshaping the surface of the cornea, removing microscopic amounts of tissue, thereby allowing images to be more sharply focused on the retina," states Dr. Sandra Belmont, director of the Laser Vision Correction Center at New York-Presbyterian Hospital and associate professor of ophthalmology at the Weill Medical College of Cornell University. The cornea is responsible for approximately 70% of the total refracting power of the eye. When a person is nearsighted, the cornea is flattened, thereby decreasing the refractive capability of the cornea; in the case of farsightedness, the cornea is given the necessary curvature, increasing the refractive power of the cornea. By altering the orientation of the cornea, surgeons are able to eliminate or lessen the need for corrective lenses. The laser procedure termed LASIK was approved by the FDA in 1995. Approximately 1 million procedures of this type were performed in the U.S. during 1999. "Laser vision correction is a onetime procedure, and the treatment itself is painless," according to Belmont. She adds that "a recent study demonstrated that 98% of patients treated for nearsightedness with this procedure were able to pass a driver's test without corrective lenses." Most patients can return to work the next day, although two or three days is recommended. A prospective patient who can benefit from this procedure must meet certain eligibility criteria. For example, the patient must have healthy eyes and have stable vision for at least one year before the procedure. Patients with degenerative or autoimmune diseases, diabetes or are pregnant or nursing are not good candidates. The patient must be at least 18 years old to treat nearsightedness and 21 years old to treat astigmatism. Before getting this treatment, the patient undergoes an extensive eye examination by a board-certified ophthalmologist. Corneal topography, a test that provides the clinician a computerized map of the eye and allows for the inspection of the shape of the cornea, is performed. High-frequency ultrasound is used as a diagnostic tool to produce an image of the eye to rule out disease. What treatment options are on the horizon for people who suffer from farsightedness? There is a new laser procedure for the treatment of farsightedness that is undergoing FDA evaluation. It is called the Sunrise LTK procedure. Unlike the LASIK procedure, LTK does not remove tissue from the cornea, but instead causes shrinking of the tissue. This gives the cornea more curvature. Many surgeons contend that this new laser technique will become the procedure of choice for correction of farsightedness in the near future. For further information on laser vision correction, check out the following Web site: www.nycornell.org/vision. Original Publication Date: 11/28/1999

To: Stephen M. DeMoss who wrote (3453)	11/29/1999 1:52:00 PM
From: TripleT	Respond to of 4140

>>The slide the panel brought to the last meeting showed they were not there to listen. Hopefully this time around will be differant.<< After reading the panel report, I sure got a different opinion than you. In the words of one positive thinker, "Some people aim at nothing and hit it with remarkable accuracy". That pretty much sums up the SNRS presentation. They set out to prove that they could some correction and not to specifically correct anyone's eyesight to 20/20 and they pretty much succeeded. This fact was what raised the ire of the board members. There was a slide on the SNRS site that alluded to this, but for once the co. showed good judgement and removed it. TTT